Open an account

Polyrizon

PLRZ · NASDAQ

$9.15−$0.535 (−5.52%)TodayMarket closed ·
Prev close $9.69

About PLRZ

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. The company is headquartered in Ra'Anana, Central(Hamerkaz) and currently employs 1 full-time employees. The company went IPO on 2024-10-29. The firm is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The firm is focused not only on the development of intranasal products, but also on commercialization. The firm cooperates with medical specialists and researchers..

Employees
1
Headquarters
Ra'anana, Central(HaMerkaz)
Listed
Oct 29, 2024
Sector
Health Care
Industry
Biotechnology
Website
polyrizon-biotech.com

PLRZ key statistics

Market cap
21.70M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
24.90K
Volume
15.91K
Open price
$9.62
High today
$10.09
Low today
$9.15
52 Week high
$18.20
52 Week low
$2.88

Polyrizon (PLRZ) at a glance

As of Oct 20, 2026, Polyrizon (PLRZ) shares are priced at $9.15, giving the company a market cap of 21.70M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $9.15 and $10.09. The current price is 0.1% above the day's low and 9.3% below its high.

Volume so far is 15.91K shares, below the average of 24.90K shares a day.

Over the past year Polyrizon has ranged from $2.88 to $18.20, and now sits 41% of the way up that range.

PLRZ news

  • Press releasePRNewswire

    Pulse Equity: Emerging Outbreaks - Polyrizon's Approach to Broad and Rapidly Deployable Protection

  • Press releasePRNewswire

    Moonage Media Spotlights Polyrizon (Nasdaq: PLRZ): Unveils NASARIX™, Drug-Free Allergy Blocker

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • Avi Kapoor

    Crude Oil Gains Over 1%; Kroger Shares Slide After Q3 Results

  • Avi Kapoor

    US Stocks Edge Higher; Dollar General Shares Jump After Upbeat Earnings

  • Mohd Haider

    What Sparked Polyrizon's (PLRZ) 140% After-Hours Stock Surge?

  • Avi Kapoor

    Why American Eagle Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Similar companies

Companies in the same industry as Polyrizon

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.